Tizanidine Tablet
Product Images NDC 67296-2263

This is a description of Tizanidine tablets. Each tablet contains 2.288 mg of Tizanidine hydrochloride USP, equivalent to 2 mg of Tizanidine base. These tablets are not interchangeable with Tizanidine capsules. It is recommended to refer to the package insert for prescribing information. The medication should be stored at 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The product is distributed by Dr. Reddy's Laboratories in India and manufactured by Northstar Rx LLC. It comes in a bottle containing 150 tablets and should be kept out of reach of children.*

This is a description of Tizanidine tablets, a medication used to treat muscle spasms. The tablets contain 4 mg of Tizanidine hydrochloride USP, equivalent to 4 mg of Tizanidine base. It is important to note that Tizanidine tablets are not interchangeable with Tizanidine capsules. The medication should be stored at 25°C (77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is advised to keep this medication out of reach of children and to dispense it in containers with child-resistant closures. The tablets are manufactured by Northstar Rx LLC in Memphis, TN, and distributed by Dr. Reddy's Laboratories Limited in India. The package contains 150 tablets.*

The text provides information on different scenarios of administration of Tizanidine tablets and capsules with or without food and the corresponding plasma concentrations at various hours post-dosing. This data can be used to understand how food intake may affect the absorption of Tizanidine and subsequently impact plasma concentrations.*

This is an evaluation of the improvement in the Ashworth Score at 16 mg tizanidine compared to placebo over hours post-dose.*

This text mentions the improvement in Ashworth Score with the drug Zanidine at a mean dose of 28.6 mg. It also states the study week 3 and the end of maintenance endpoint at study week 7 using the Last Observation Carried Forward method.*